US 10011833
Bridged bicyclic nucleosides
granted A61PA61P1/16A61P11/00
Quick answer
US patent 10011833 (Bridged bicyclic nucleosides) held by MIRAGEN THERAPEUTICS, INC. expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P21/00